{"id":"https://openalex.org/W4414407337","doi":"https://doi.org/10.1038/s41577-025-01228-4","title":"Clearing the hurdles for CAR-T cell treatment","display_name":"Clearing the hurdles for CAR-T cell treatment","publication_year":2025,"publication_date":"2025-09-22","ids":{"openalex":"https://openalex.org/W4414407337","doi":"https://doi.org/10.1038/s41577-025-01228-4","pmid":"https://pubmed.ncbi.nlm.nih.gov/40983714"},"language":"en","primary_location":{"id":"doi:10.1038/s41577-025-01228-4","doi":"https://doi.org/10.1038/s41577-025-01228-4","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41577-025-01228-4","pdf_url":null,"source":{"id":"https://openalex.org/S93373720","display_name":"Nature reviews. Immunology","issn_l":"1474-1733","issn":["1474-1733","1474-1741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015555817","display_name":"Rayne Helen Rouce","orcid":"https://orcid.org/0000-0002-0670-0599","observed_orcids":["https://orcid.org/0000-0002-0670-0599"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]},{"id":"https://openalex.org/I4390039366","display_name":"Dan L Duncan Comprehensive Cancer Center","ror":"https://ror.org/02nre0x31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370","https://openalex.org/I4390039366"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rayne H. Rouce","raw_affiliation_strings":["Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA. rouce@bcm.edu","Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA. rouce@bcm.edu","Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. rouce@bcm.edu","Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA. rouce@bcm.edu","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]},{"raw_affiliation_string":"Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA. rouce@bcm.edu","institution_ids":["https://openalex.org/I181547552","https://openalex.org/I4390039366"]},{"raw_affiliation_string":"Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. rouce@bcm.edu","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA","institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5015555817"],"corresponding_institution_ids":["https://openalex.org/I1295876152","https://openalex.org/I181547552","https://openalex.org/I4210147586","https://openalex.org/I4390039366"],"apc_list":null,"apc_paid":null,"fwci":2.0738,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.88900011,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"25","issue":"11","first_page":"777","last_page":"779"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9599999785423279},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor","display_name":"chimeric antigen receptor","score":0.7739999890327454},{"id":"https://openalex.org/keywords/access-to-cancer-treatment","display_name":"access to cancer treatment","score":0.7839999794960022},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.46799999475479126},{"id":"https://openalex.org/keywords/regulatory-approval","display_name":"regulatory approval","score":0.4519999921321869},{"id":"https://openalex.org/keywords/equitable-access-to-treatment","display_name":"equitable access to treatment","score":0.6679999828338623},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.4449999928474426}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.8611999750137329},{"id":"https://openalex.org/C134697681","wikidata":"https://www.wikidata.org/wiki/Q1609677","display_name":"Clearing","level":2,"score":0.6237000226974487},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4668999910354614},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.43369999527931213},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4023999869823456},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3758000135421753},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34200000762939453},{"id":"https://openalex.org/C10882517","wikidata":"https://www.wikidata.org/wiki/Q15268054","display_name":"Cell therapy","level":3,"score":0.3377000093460083},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.33250001072883606},{"id":"https://openalex.org/C2777210771","wikidata":"https://www.wikidata.org/wiki/Q4927124","display_name":"Block (permutation group theory)","level":2,"score":0.31940001249313354},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.2944999933242798},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.27649998664855957},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.26649999618530273},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.25760000944137573},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.25679999589920044},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.25049999356269836}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1038/s41577-025-01228-4","doi":"https://doi.org/10.1038/s41577-025-01228-4","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41577-025-01228-4","pdf_url":null,"source":{"id":"https://openalex.org/S93373720","display_name":"Nature reviews. Immunology","issn_l":"1474-1733","issn":["1474-1733","1474-1741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Immunology","raw_type":"journal-article"},{"id":"pmid:40983714","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40983714","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature reviews. Immunology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482},{"display_name":"Reduced inequalities","id":"https://metadata.un.org/sdg/10","score":0.7390999794006348}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W2787301955","https://openalex.org/W2800595080","https://openalex.org/W2903062212","https://openalex.org/W3023211384","https://openalex.org/W3160133442","https://openalex.org/W4319656360","https://openalex.org/W4377043777","https://openalex.org/W4387373510","https://openalex.org/W4387956501","https://openalex.org/W4400474295","https://openalex.org/W4401211143","https://openalex.org/W4402236299","https://openalex.org/W4402471159","https://openalex.org/W4409100966","https://openalex.org/W4411603000","https://openalex.org/W4413759647"],"related_works":["https://openalex.org/W4281665399","https://openalex.org/W4296714474","https://openalex.org/W7118188211","https://openalex.org/W4403567626","https://openalex.org/W3165864905","https://openalex.org/W3023211384","https://openalex.org/W4410382981","https://openalex.org/W4235802862","https://openalex.org/W7223054341","https://openalex.org/W4313324362"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":5}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-10-10T00:00:00"}